Review of 2005 Public Health Laboratory Network Neisseria gonorrhoeae nucleic acid amplification tests guidelines
DOI:
https://doi.org/10.33321/cdi.2015.39.6Keywords:
gonorrhoea, nucleic acid amplification tests, NAAT, supplementary testingAbstract
At the request of the Public Health Laboratory Network (PHLN), the National Neisseria Network (NNN) met to discuss the 2009 PHLN Neisseria gonorrhoeae nucleic acid amplification test (NAAT) guidelines and the need for supplementary testing. A central point of discussion at this NNN meeting, which took place in May 2013, was the potential for N. gonorrhoeae supplementary testing to lead to false-negative results. Data were presented at the meeting that questioned the sensitivity of commonly used in-house supplementary methods as compared with later generation commercial NAAT systems. It was the opinion of the NNN that supplementary testing remains best practice, but that caution should be used when reporting negative results. The NNN recommends that urogenital samples providing a positive result in a screening method and a negative result by a supplemental method should not be reported as negative for N. gonorrhoeae without an appropriate explanatory comment indicating that gonococcal infection cannot be excluded. Commun Dis Intell 2015;39(1):E42–E45.
Downloads
References
Linz B, Schenker M, Zhu P, Achtman M. Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis. Mol Microbiol 2000;36(5):1049–1058.
Marri PR, Paniscus M, Weyand NJ, Rendón MA, Calton CM, Hernández DR, et al. Genome sequencing reveals widespread virulence gene exchange among human Neisseria species. PLoS One 2010;5(7):e11835.
Whiley DM, Tapsall JW, Sloots TP. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn 2006;8(1):3–15.
Smith DW, Tapsall JW, Lum G. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun Dis Intell 2005;29(4):358–365.
Whiley DM, Limnios A, Moon NJ, Gehrig N, Goire N, Hogan T, et al. False-negative results using Neisseria gonorrhoeae porA pseudogene PCR—a clinical gonococcal isolate with an N. meningitidis porA sequence, Australia, March 2011. Euro Surveill 2011;16(21)pii:19874.
Lum G, Freeman K, Nguyen NL, Limnios EA, Tabrizi SN, Carter I, et al. A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR. Sex Transm Infect 2005;81(5):400–402.
Trembizki E, Lahra M, Stevens K, Freeman K, Hogan T, Hogg G, et al. A national quality assurance survey of Neisseria gonorrhoeae testing. J Med Microbiol 2014;63(Pt 1):45–49.
Tabrizi SN, Unemo M, Limnios AE, Hogan TR, Hjelmevoll SO, Garland SM, et al. Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species. J Clin Microbiol 2011;49(10):3610–3615.
Upton A, Bromhead C, Whiley DM. Neisseria gonorrhoeae false-positive result obtained from a pharyngeal swab by using the Roche cobas 4800 CT/NG assay in New Zealand in 2012. J Clin Microbiol 2013;51(5):1609–1610.
Walcher M, Skvoretz R, Montgomery-Fullerton M, Jonas V, Brentano S. Description of an unusual Neisseria meningitidis isolate containing and expressing Neisseria gonorrhoeae-specific 16S rRNA gene sequences. J Clin Microbiol 2013;51(10):3199–3206.
British Association of Sexual Health and HIV, Clinical Effectiveness Group 2012. United Kingdom National Guideline for Gonorrhoea Testing 2012. [online] Available from: http://www.bashh.org/documents/4490.pdf
Centers for Disease Control and Prevention. Recommendations for the Laboratory-Based Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. 2014. [online] Available from http://www.cdc.gov/std/laboratory/2014LabRec/recommendations2.htm
Downloads
Published
How to Cite
License
Copyright (c) 2015 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
